LMR Partners »

Kalvista Pharmaceuticals shares owned by LMR Partners

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by LMR Partners from 13F filings

Historical chart of LMR Partners investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by LMR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by LMR Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $306k 25k 12.25
2023-09-30 $241k 25k 9.63
2021-03-31 $642k 25k 25.68

More positions owned by LMR Partners

Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microstrategy Cl A New Put Option (MSTR)
Ishares Tr National Mun Etf Put Option (MUB)
Vaneck Etf Trust Semiconductr Etf (SMH)
Spdr Ser Tr S&p Oilgas Exp Put Option (XOP)
NVIDIA Corporation Put Option (NVDA)
Capri Holdings SHS (CPRI)
Tripadvisor (TRIP)
Microsoft Corporation (MSFT)
BP Sponsored Adr (BP)
Advanced Micro Devices Call Option (AMD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr China Lg-cap Etf (FXI)
Stellantis SHS Put Option (STLA)

View all positions for LMR Partners

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Suvretta Capital Management
Tang Capital Management
Frazier Life Sciences Management
Adage Capital Partners GP
BlackRock
Vanguard Group
Boxer Capital
Saturn V Capital Management
First Turn Management
DAFNA Capital Management
MPM Oncology Impact Management
Emerald Advisers
Geode Capital Management
Marshall Wace

View all funds holding Kalvista Pharmaceuticals